
Will Merck shareholders get Organon stock?
Could you elaborate on the potential implications for Merck shareholders regarding the distribution of Organon stock? Specifically, are there any plans to issue Organon shares directly to Merck shareholders, and if so, what are the proposed terms and conditions? Furthermore, will Merck shareholders have any voting rights or influence over Organon's business decisions after the potential spin-off? Additionally, what are the potential risks and opportunities for Merck shareholders associated with this transaction?


Why is Organon stock falling?
I've noticed a significant decline in Organon's stock price recently, and I'm curious to understand the reasons behind this trend. Could you elaborate on any potential factors that might be contributing to the drop? Is it due to market conditions, a lack of positive earnings reports, or perhaps some unfavorable news surrounding the company? I'm also wondering if investors are becoming concerned about Organon's long-term prospects or if there's a shift in sentiment towards the industry as a whole. Any insights you can provide would be greatly appreciated.
